Christopher Paul Simms
Chief Commercial and Business Officer · 4D Molecular Therapeutics, Inc.
Individual
- 2026
- Mar 27, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Christopher Paul Simms files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David Kirn - $5.01M in FDMT purchases and sales in the last 12 months
- Scott Bizily - $364K in FDMT purchases and sales in the last 12 months
- Ashoo Gupta - $7K in FDMT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Christopher Paul Simms?
Christopher Paul Simms is a corporate insider, tracked as Chief Commercial and Business Officer of 4D Molecular Therapeutics, Inc. (FDMT). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Christopher Paul Simms last file a Form 4?
The only primary Form 4 on record is dated 27 March 2026.